Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral immunization with Sendai virus in mice.

J G Nedrud, X P Liang, M E Lamm

    Current Topics in Microbiology and Immunology
    |January 1, 1989
    PubMed
    Summary

    Cholera toxin acts as an effective adjuvant for gastrointestinal immune responses against viruses in mice. Covalently linking virus and toxoid enhances adjuvant properties while reducing toxicity, priming respiratory immunity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Clinical characteristics and prognostic features of 63 HIV-associated diffuse large B-cell lymphoma: a single-center real-world study in China].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2022
    Same author

    [Peripheral nerve injury in LAMA2-related congenital muscular dystrophy patients].

    Zhonghua er ke za zhi = Chinese journal of pediatrics·2017
    Same author

    T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.

    Clinical and experimental immunology·2008
    Same author

    Helicobacter animal models.

    Current protocols in immunology·2008
    Same author

    The role of nasal tolerance in a model of IgA nephropathy induced in mice by Sendai virus.

    Clinical immunology (Orlando, Fla.)·2004
    Same author

    T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

    Clinical and experimental immunology·2001

    Area of Science:

    • Immunology
    • Virology
    • Vaccine Development

    Background:

    • Cholera toxin (CT) is a potent mucosal adjuvant.
    • Viral infections pose significant health challenges, necessitating effective vaccine strategies.
    • Developing vaccines that elicit robust mucosal and systemic immunity is crucial.

    Purpose of the Study:

    • To evaluate cholera toxin as an adjuvant for gastrointestinal immune responses against a viral infection in mice.
    • To investigate if covalent linkage of virus and cholera toxoid can enhance adjuvant properties and reduce toxicity.
    • To determine the efficacy of oral immunization with these preparations in priming respiratory immune responses.

    Main Methods:

    • Oral immunization of mice with cholera toxin and Sendai virus.
    • Covalent linkage of Sendai virus and cholera toxoid to create novel vaccine candidates.
    • Assessment of gastrointestinal and respiratory immune responses, including IgA and IgG antibody levels.
    • Correlation of immune responses with protection from viral infection.

    Main Results:

    • Cholera toxin effectively enhanced gastrointestinal immune responses against a virus in mice.
    • Covalent linkage of virus and toxoid increased adjuvant properties and dissociated them from toxicity.
    • Oral immunization primed effective respiratory immune responses to Sendai virus.
    • Protection from infection correlated with specific antibody isotypes in different respiratory tract regions (IgA upper, IgG lower).

    Conclusions:

    • Cholera toxin serves as a promising adjuvant for oral vaccines targeting viral infections.
    • Modified cholera toxin (toxoid) offers an improved safety and efficacy profile.
    • Oral immunization strategies using these preparations can induce protective immunity in the respiratory tract.

    Related Experiment Videos